« Back
Home /
Anecortave Acetate

Anecortave Acetate

Item no.	TMO-T21452-1g
Manufacturer	TargetMol
CASRN	7753-60-8
Amount	1 g
Quantity options	1000 mg 100 mg 10 mg 1 g 200 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	Stalmans I, Callanan DG, Dirks MS, Moster MR, Robin AL, Van Calster J, Scheib SA, Dickerson JE Jr, Landry TA, Bergamini MV. Treatment of steroid-induced elevated intraocular pressure with anecortave acetate: a randomized clinical trial. J Ocul Pharmacol Ther. 2012 Dec;28(6):559-65. doi: 10.1089/jop.2012.0063. Epub 2012 Aug 3. PubMed PMID: 22860637; PubMed Central PMCID: PMC3505827.
Smiles	C[C@@]12[C@]([C@]3(C([C@]4(C)C(CC3)=CC(=O)CC4)=CC1)[H])(CC[C@@]2(C(COC(C)=O)=O)O)[H]
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Retaane,Al 3789,NSC 24345,NSC 15475,Anecortave
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Others
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	386.48
Description	Anecortave Acetate (NSC-24345), an angiostatic steroid, is used for proteomics research.
Pathways	Others
Bioactivity	Anecortave Acetate, an angiostatic steroid, is used for proteomics research.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T21452-1g-datasheet.pdf

TMO-T21452-1g-safety-datasheet.pdf